Notification according to Chapter 2, Section 10 of the Finnish Securities Market Act

BIOTIE THERAPIES CORP.    STOCK EXCHANGE RELEASE 15 March 2011 at 6.30 p.m.

Notification according to Chapter 2, Section 10 of the Finnish Securities Market
Act

Biotie Therapies Corp. ("Company" or "Biotie") has gained knowledge of a
notification regarding changes in holdings in accordance with Chapter 2, Section
9 of the Finnish Securities Markets Act, described below.

The notification received by the Company concerns the changes in holdings of
Invesco Limited (through Invesco Fund Managers Limited)

The mentioned change in holdings is related to the private placement of shares
(the "Offering") described in more detail in a stock exchange release issued on
11.3.2011. In the Offering a total of 35,230,000 newly issued and 14,747,084
treasury shares were offered to Finnish and international institutional and
strategic investors.

After completion of the Offering and the registration with the Finnish Trade
Register of the new shares issued, the resulting holdings of shares and votes in
the Company of Invesco Limited (through Invesco Fund Managers Limited) would be
as follows:

Name         Number of      Number of      Number of     Share of    Share of
             shares before  voting rights  shares and    share       voting
             the Offering   before the     voting rights capital     rights
                            Offering       after the     after the   after the
                                           Offering      Offering    Offering
                                                         (%)         (%)

Invesco      14,432,000     14,432,000     44,273,256    11.42 %     11.88 %
Limited
(through
Invesco Fund
Managers
Limited)

Total        14,432,000     14,432,000     44,273,256    11.42 %     11.88 %




The number of voting rights and percentages presented above are calculated based
on number of shares and voting rights upon completion of the Offering taking
into account the treasury shares held by the Company or its group companies upon
completion of the Offering.

On the date hereof, the registered number of shares in Biotie is 352,364,457. Of
these shares 29,659,239 are held by the Company or its group companies and the
number of outstanding shares and voting rights attached to the shares thus
amounts to 322,705,218. Subsequent to the completion of the Offering and the
registration of the new shares issued in the Offering, the aggregate number of
Biotie shares will be 387,594,457. Of these shares, 14,912,155 will be held by
the Company or its group companies.



Turku, 15 March 2011

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail:virve.nurmi@biotie.com

DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com




[HUG#1497132]